Found: 6
Select item for more details and to access through your institution.
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
- Published in:
- Oncology Reports, 2014, v. 32, n. 1, p. 159, doi. 10.3892/or.2014.3195
- By:
- Publication type:
- Article
Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2311, doi. 10.1007/s00262-012-1298-1
- By:
- Publication type:
- Article
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 623, doi. 10.1186/1471-2407-12-623
- By:
- Publication type:
- Article
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm.
- Published in:
- Cancer Science, 2011, v. 102, n. 4, p. 690, doi. 10.1111/j.1349-7006.2011.01866.x
- By:
- Publication type:
- Article
Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm.
- Published in:
- 2011
- By:
- Publication type:
- Other